Phase II trial of 5,6-dihydro-5-azacytidine in pleural malignant mesothelioma

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Investigational new drugs

• Publication date

  1991-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF00194548PMID 1709153
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phase II study of 5,6-dihydro-5-azacytidine in extensive, untreated non-small cell lung cancer.

  1987cited by this paper
• Fetal hemoglobin gene activation in a phase II study of 5,6-dihydro-5-azacytidine for bronchogenic carcinoma.

  1987cited by this paper
• A phase I and pharmacokinetic study of dihydro-5-azacytidine (NSC 264880).

  1985cited by this paper
• Malignant mesothelioma of the pleura: a study of 52 treated and 64 untreated patients.

  1984cited by this paper
• Malignant mesothelioma 1982: review of 4710 published cases.

  1983cited by this paper
• Diffuse malignant mesothelioma. Prospective evaluation of 69 patients.

  1982cited by this paper
• Synthesis and antitumor activity of dihydro-5-azacytidine, a hydrolytically stable analogue of 5-azacytidine.

  1977cited by this paper
• SYNTHESIS AND ANTITUMOR ACTIVITY OF DIHYDRO-5-AZACYTIDINE, A HYDROLYTICALLY STABLE ANALOG OF 5-AZACYTIDINE

  1977cited by this paper

• Nucleosidic DNA demethylating epigenetic drugs - A comprehensive review from discovery to clinic.

  2018cites this paper
• Epigenetic Therapy of Cancer

  2015cites this paper
• Malignant pleural mesothelioma: medical treatment update.

  2009cites this paper
• DNA (cytosine-5)-methyltransferase 1 - (Isoform 1)

  2009cites this paper
• Other Approaches to Targeted Therapy

  2008cites this paper
• Tumors of the Pleura and Mediastinum

  2008cites this paper
• Epigenetics in Biology and Medicine

  2008cites this paper
• The Use of Chemotherapy in Patients with Advanced Malignant Pleural Mesothelioma: A Systematic Review and Practice Guideline

  2006cites this paper
• 4.2. Chimiothérapie du mésothéliome pleural malin

  2006cites this paper
• Chemotherapy in malignant mesothelioma: a review

  2004cites this paper
• DNA methyltransferase inhibitors-state of the art.

  2002cites this paper
• Chemotherapy for malignant mesothelioma: from doxorubicin to vinorelbine.

  2002cites this paper
• Pleural mesothelioma: combined modality treatments

  2002cites this paper
• The value of positron emission tomography (PET) imaging in disease staging and therapy assessment.

  2002cites this paper
• Activity of chemotherapy and immunotherapy on malignant mesothelioma: a systematic review of the literature with meta-analysis.

  2002cites this paper
• The emerging role of antifolates in the treatment of malignant pleural mesothelioma.

  2002cites this paper
• Pleura mesothelioma: combined modality treatments.

  2002cites this paper
• A review of chemotherapy trials for malignant mesothelioma.

  1998cites this paper
• Dihydro‐5‐azacytidine in malignant mesothelioma

  1997cites this paper
• Chemotherapy in malignant pleural mesothelioma. A review.

  1996cites this paper
• Current approach to malignant mesothelioma of the pleura.

  1995cites this paper
• An extended phase II trial of ifosfamide plus mesna in malignant mesothelioma

  1992cites this paper